BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6761807)

  • 1. [Platelet aggregation and antiaggregant drugs].
    Andriani A; Chiappetta MG; Fabiani M
    Recenti Prog Med; 1982 Nov; 73(5):537-42. PubMed ID: 6761807
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
    Tuong CC; Ferrand C; Aubert D; Loubrie JC; Tuong A
    Biochem Pharmacol; 1982 Mar; 31(6):1147-50. PubMed ID: 7200772
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ticlopidine as something more than a platelet antiaggregant].
    Villaverde C; Cánovas M; Padró T; Navarro C
    Arch Farmacol Toxicol; 1984 Aug; 10(2):121-32. PubMed ID: 6517621
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological studies on ticlopidine, a new platelet aggregation inhibitor. Part I: Cardiovascular effects.
    Akashi A; Tamura K; Hirohashi M; Watanabe K; Kasahara A
    Arzneimittelforschung; 1980; 30(3):409-14. PubMed ID: 7387750
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombus formation and its prevention during extracorporeal circulation--effect of preoperative administration with the antiplatelet drugs].
    Takayama T
    Nihon Kyobu Geka Gakkai Zasshi; 1984 Dec; 32(12):2076-89. PubMed ID: 6530570
    [No Abstract]   [Full Text] [Related]  

  • 6. Rationale for the use of drugs inhibiting platelet function in claudicating patients with atherosclerotic leg arteries.
    Verstraete M
    Agents Actions Suppl; 1984; 15():173-87. PubMed ID: 6091423
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of the influence of nitroglycerin on the synthesis of prostaglandins and thromboxane A2 and on platelet aggregation.
    Rettkowski W; Pönicke K; Block HU; Giessler C; Dunemann A; Zehl U; Förster W
    Arzneimittelforschung; 1982; 32(3):194-200. PubMed ID: 6805480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of chlorpromazine, dipyridamole and verapamil on platelet aggregation on the arachidonic acid metabolism].
    Zucchella M; Pacchiarini L; Grignani G
    Boll Soc Ital Biol Sper; 1987 Dec; 63(12):1137-44. PubMed ID: 3135826
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative action of different platelet anti-aggregants in the postoperative period].
    Lapeyrère X; Gruyer P; Guyot L; Barbe G; Saint-Paul B
    Cah Anesthesiol; 1984 Mar; 32(2):123-5. PubMed ID: 6529644
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of prostaglandins and thromboxane A2 for the mode of action of cardiovascular drugs.
    Förster W
    Adv Prostaglandin Thromboxane Res; 1980; 7():609-18. PubMed ID: 6989188
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of prostacyclin and thromboxane A2 in the regulation of platelet behaviour.
    Moncada S
    Mater Med Pol; 1980; 12(3):207-12. PubMed ID: 7019591
    [No Abstract]   [Full Text] [Related]  

  • 12. [Technological and biopharmaceutical aspects. Antiplatelet agents for oral administration].
    Breitkreutz J
    Pharm Unserer Zeit; 2009; 38(4):330-7. PubMed ID: 19572353
    [No Abstract]   [Full Text] [Related]  

  • 13. Dipyridamole and platelet aggregation.
    Lancet; 1978 Jul; 2(8083):270. PubMed ID: 79070
    [No Abstract]   [Full Text] [Related]  

  • 14. Dipyridamole and platelet function.
    Lancet; 1978 Dec; 2(8102):1257-9. PubMed ID: 82767
    [No Abstract]   [Full Text] [Related]  

  • 15. Antithrombotic effects of ticlopidine, acetylsalicyclic acid and dipyridamole in vascular shunt model in rats.
    Ashida S; Sakuma K; Abiko Y
    Thromb Res; 1980 Mar; 17(5):663-71. PubMed ID: 7385100
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiaggregant effect of ticlopidine in atherosclerotic patients.
    Manotti C; Potì R; Megna A; Poli T; Alberani M
    Farmaco Prat; 1982 Oct; 37(10):325-30. PubMed ID: 7140941
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective.
    de Gaetano G; Bertelé V
    Arq Bras Cardiol; 1983 Dec; 41(6):425-7. PubMed ID: 6678584
    [No Abstract]   [Full Text] [Related]  

  • 18. Ticlopidine and platelet function.
    Lecompte T; Lecrubier C; Potevin F; Samama M
    Thromb Haemost; 1986 Jun; 55(3):437-8. PubMed ID: 3529484
    [No Abstract]   [Full Text] [Related]  

  • 19. [Animal experiment studies on the inhibition of platelet aggregation by verapamil in vitro and in vivo].
    Kreiskott H; Hofmann HP
    Arzneimittelforschung; 1973 Nov; 23(11):1555-60. PubMed ID: 4801662
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of platelet aggregation in patients treated with ticlopidine].
    Sbalzarini G; Carniti E; Fiorini L; Iezzi BG
    Clin Ter; 1984 Nov; 111(3):247-50. PubMed ID: 6240365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.